October 21, 2026StocksTechnology·Bullish·regulatory
Edwards Lifesciences receives FDA approval for tricuspid valve repair system
The US FDA granted approval to Edwards Lifesciences for its tricuspid valve repair system, expanding the company's treatment options for structural heart disease patients with tricuspid valve conditions.
Detected & updated continuously · Source: Nebula
Story subjects
Edwards Lifesciences CorpFood and Drug Administration